naringenin and Colorectal Cancer

naringenin has been researched along with Colorectal Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Abalo, R; Capasso, R; Entrialgo-Cadierno, R; Fernández, J; Lombó, F; Silván, B; Uranga, JA; Villar, CJ1
Abdullah, S; Alhakamy, NA; Awan, ZA; Md, S1
Chaurasia, S; Mishra, B; Patel, RR; Vure, P1
Bode, AM; Chen, H; Cheng, KW; Dong, Z; Li, H; Lubet, RA; Oi, N; Wang, M; Zhu, F; Zykova, T1
Cheng, KW; Fan, D; Hu, S; Li, ET; Ru, B; Wang, M; Zhang, J; Zhao, Y1
Cho, SG; Choi, HY; Jeong, HS; Kang, GH; Kang, YJ; Kim, BW; Kim, HJ; Kim, JH; Lee, ER; Park, YS1

Reviews

1 review(s) available for naringenin and Colorectal Cancer

ArticleYear
Antiproliferative and palliative activity of flavonoids in colorectal cancer.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 143

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Flavanones; Flavonoids; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Luteolin; Palliative Care; Propiophenones

2021

Other Studies

5 other study(ies) available for naringenin and Colorectal Cancer

ArticleYear
Smart Oral pH-Responsive Dual Layer Nano-Hydrogel for Dissolution Enhancement and Targeted Delivery of Naringenin Using Protein-Polysaccharides Complexation Against Colorectal Cancer.
    Journal of pharmaceutical sciences, 2022, Volume: 111, Issue:11

    Topics: Colorectal Neoplasms; Delayed-Action Preparations; Flavanones; Humans; Hydrogels; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Polysaccharides; Solubility; Soybean Proteins; Spectroscopy, Fourier Transform Infrared; Water

2022
Oral naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments.
    Nanomedicine (London, England), 2017, Volume: 12, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Cell Line, Tumor; Colon; Colorectal Neoplasms; Drug Carriers; Female; Flavanones; Humans; Male; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polysaccharides; Rats, Wistar; Rectum

2017
6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.
    Cancer research, 2014, Jan-01, Volume: 74, Issue:1

    Topics: Animals; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Flavanones; HT29 Cells; Humans; Male; Mice; Mice, Nude; Transfection; Xenograft Model Antitumor Assays

2014
6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 68

    Topics: Autophagy; Autophagy-Related Protein 7; Beclin-1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Inhibitors; Farnesol; Flavanones; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; HT29 Cells; Humans; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Necrosis; Phosphatidylinositol 3-Kinases; Protein Methyltransferases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; ras Proteins; Salicylates; TOR Serine-Threonine Kinases

2016
Regulation of apoptosis by modified naringenin derivatives in human colorectal carcinoma RKO cells.
    Journal of cellular biochemistry, 2008, May-01, Volume: 104, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Flavanones; Flavonoids; Humans; Hydroxylation; Reactive Oxygen Species; Structure-Activity Relationship

2008